Inventor
PINTO DONALD J P
US85 patents
⚠️ This page may combine multiple inventors who share the name “PINTO DONALD J P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
25 patentsUS7115627B2Oct 3, 2006
Glycinamides as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO101 citations96
US6602895B2Aug 5, 2003
Inhibitors of factor Xa with a neutral P1 specificity group
BRISTOL MYERS SQUIBB CO80 citations96
US8367709B2Feb 5, 2013
Dipeptide analogs as coagulation factor inhibitors
BRISTOL MYERS SQUIBB CO42 citations94
US6407256B1Jun 18, 2002
Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO23 citations93
US9453018B2Sep 27, 2016
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO13 citations92
US7626039B2Dec 1, 2009
Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO14 citations92
US6599926B2Jul 29, 2003
Heteroaryl-phenyl substituted factor Xa inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US10487086B2Nov 26, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US10208068B2Feb 19, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9902742B2Feb 27, 2018
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9802939B2Oct 31, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US9611274B2Apr 4, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9192607B2Nov 24, 2015
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US9108951B2Aug 18, 2015
Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9000172B2Apr 7, 2015
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US7338963B2Mar 4, 2008
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO9 citations84
US7371761B2May 13, 2008
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO12 citations83
US7960411B2Jun 14, 2011
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO4 citations74
US7691846B2Apr 6, 2010
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO6 citations74
US7645799B2Jan 12, 2010
Substituted biaryl compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021
Macrocycles as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US9944625B2Apr 17, 2018
Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US7235575B2Jun 26, 2007
Guanidine mimics as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US11053247B2Jul 6, 2021
Pyrimidinones as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10336754B2Jul 2, 2019
Pyrimidinones as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
BRISTOL MYERS SQUIBB PHARMA CO
12 patentsUS6967208B2Nov 22, 2005
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO100 citations98
US6548525B2Apr 15, 2003
Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO125 citations96
US6989391B2Jan 24, 2006
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO59 citations95
US6500855B1Dec 31, 2002
Thrombin or factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO40 citations95
US6369227B1Apr 9, 2002
Thrombin or factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO44 citations95
US6995172B2Feb 7, 2006
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO19 citations93
US6436985B2Aug 20, 2002
Disubstituted pyrazolines and triazolines as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO21 citations93
US7005435B2Feb 28, 2006
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO19 citations92
US6906070B2Jun 14, 2005
Guanidine mimics as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO13 citations92
US6602871B2Aug 5, 2003
Thrombin or factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO20 citations92
US6506771B2Jan 14, 2003
Heteroaryl-phenyl heterobicyclic factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO35 citations92
US6413980B1Jul 2, 2002
Nitrogen containing heterobicycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO41 citations92
DU PONT PHARM CO
4 patentsUS6339099B1Jan 15, 2002
Guanidine mimics as factor Xa inhibitors
DU PONT PHARM CO128 citations98
US5998424ADec 7, 1999
Inhibitors of factor Xa with a neutral P1 specificity group
DU PONT PHARM CO163 citations97
US6191159B1Feb 20, 2001
Disubstituted pyrazolines and triazolines as factor Xa inhibitors
DU PONT PHARM CO73 citations96
US6271237B1Aug 7, 2001
Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
DU PONT PHARM CO57 citations94
DU PONT MERCK PHARMA
3 patentsUS5593994AJan 14, 1997
Prostaglandin synthase inhibitors
DU PONT MERCK PHARMA251 citations98
US5244917ASep 14, 1993
Substituted naphthofurans as anti-inflammatory agents
DU PONT MERCK PHARMA22 citations92
US5939418AAug 17, 1999
Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors
DU PONT MERCK PHARMA19 citations81
(unassigned)
3 patentsPINTO DONALD J P
1 patentBRISTOL MEYERS SQUIBB CO
1 patentCORTE JAMES R
1 patentShowing the top 50 of 85 patents by PatentIndex Score.